Article
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Life After Medical Affairs: From MSL to M & A
Summary
In this episode, Steve St. Onge shares his unique journey from traditional MSL roles to business development at Paratek. He discusses his background, transition to industry, and involvement in nontraditional MSL work. Steve delves into the challenges faced during his shift to business development and highlights essential skills for success in this area. The conversation also touches on overcoming the glass ceiling in medical affairs and leveraging medical affairs expertise in business roles. Steve offers valuable advice for MSLs considering a move into M&A or business development, emphasizing the importance of company research and utilizing LinkedIn for career advancement.
This episode features Steve St. Onge, Sr Director Business Development at Paratek discusses his career path from Medical Affairs to Business Development (M and A) and how he got there
We discuss….
👉 How he transitioned from Medical Affairs to M and A
👉 What his role in Business Development and M and A entails
👉 The difference between Corporate Development and Business Development
👉 Why LinkedIn can be an MSLs worst enemy
👉 The “glass ceiling” in Medical Affairs
👉 Why you need to learn the DNA of a company
St. Onge, MSL to Business Development, Paratek career transition, overcoming glass ceiling in medical affairs, LinkedIn for career advancement
Related Topics
You May Also Like
Kushal T. Kadakia, MSc, Malke Asaad, MD, Erica Adlakha, MS, Michael J. Overman, MD, Cristina M. Checka, MD, and Anaeze C. Offodile II, MD, MPH
Article
Emmanuelle Jacqueta, Ghania Kerouani-Lafayeb, Francoise Grudeb, Sergio Goncalvesb, Annie Lorenced, Florence Turcryb, Liora Brunelb, Laetitia Belgodereb, Adrien Monardc, Gaëlle Guyaderb, Lotfi Boudalib, Nicolas Albin
Comparative study on anticancer drug access times between FDA, EMA and the French temporary authorisation for use program over 13 years
Article
Aaron S. Long, BS; Audrey D. Zhang, MD; Caitlin E. Meyer, MLIS; Alexander C. Egilman, BS; Joseph S. Ross, MD, MHS; Joshua D. Wallach, PhD, MS
Evaluation of Trials Comparing Single-Enantiomer Drugs to Their Racemic Precursors: A Systematic Review
Article
iNIZIO
Transforming oncology: Five frontiers driving progress in cancer care
Article
iNIZIO
Virtual Oncology MSL Team Increases KOL Engagement by 120%
Article
Jayson L. Parker, Sebnem S. Kuzulugil, Kirill Pereverzev, Stephen Mac, Gilberto Lopes, Zain Shah, Ashini Weerasinghe, Daniel Rubinger, Adam Falconi, Ayse Bener, Bora Caglayan, Rohan Tangri, Nicholas Mitsakakis